185 related articles for article (PubMed ID: 17376040)
41. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease.
Araya J; Rodrigo R; Videla LA; Thielemann L; Orellana M; Pettinelli P; Poniachik J
Clin Sci (Lond); 2004 Jun; 106(6):635-43. PubMed ID: 14720121
[TBL] [Abstract][Full Text] [Related]
42. Dietary iron restriction improves aminotransferase levels in chronic hepatitis C patients.
Iwasa M; Kaito M; Ikoma J; Kobayashi Y; Tanaka Y; Higuchi K; Takeuchi K; Iwata K; Watanabe S; Adachi Y
Hepatogastroenterology; 2002; 49(44):529-31. PubMed ID: 11995488
[TBL] [Abstract][Full Text] [Related]
43. Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.
Furuya CK; de Oliveira CP; de Mello ES; Faintuch J; Raskovski A; Matsuda M; Vezozzo DC; Halpern A; Garrido AB; Alves VA; Carrilho FJ
J Gastroenterol Hepatol; 2007 Apr; 22(4):510-4. PubMed ID: 17376042
[TBL] [Abstract][Full Text] [Related]
44. A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease.
Fernández-Miranda C; Pérez-Carreras M; Colina F; López-Alonso G; Vargas C; Solís-Herruzo JA
Dig Liver Dis; 2008 Mar; 40(3):200-5. PubMed ID: 18261709
[TBL] [Abstract][Full Text] [Related]
45. Microvesicular fat, inter cellular adhesion molecule-1 and regulatory T-lymphocytes are of importance for the inflammatory process in livers with non-alcoholic steatohepatitis.
Söderberg C; Marmur J; Eckes K; Glaumann H; Sällberg M; Frelin L; Rosenberg P; Stål P; Hultcrantz R
APMIS; 2011 Jul; 119(7):412-20. PubMed ID: 21635548
[TBL] [Abstract][Full Text] [Related]
46. Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease.
Senturk O; Kocaman O; Hulagu S; Sahin T; Aygun C; Konduk T; Celebi A
Intern Med J; 2008 Mar; 38(3):183-9. PubMed ID: 17725609
[TBL] [Abstract][Full Text] [Related]
47. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.
Aigner E; Theurl I; Haufe H; Seifert M; Hohla F; Scharinger L; Stickel F; Mourlane F; Weiss G; Datz C
Gastroenterology; 2008 Aug; 135(2):680-8. PubMed ID: 18505688
[TBL] [Abstract][Full Text] [Related]
48. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.
Valenti L; Fracanzani AL; Dongiovanni P; Bugianesi E; Marchesini G; Manzini P; Vanni E; Fargion S
Am J Gastroenterol; 2007 Jun; 102(6):1251-8. PubMed ID: 17391316
[TBL] [Abstract][Full Text] [Related]
49. Evaluating the efficacy and safety of Danning Pian in the short-term treatment of patients with non-alcoholic fatty liver disease: a multicenter clinical trial.
Fan JG;
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):375-80. PubMed ID: 15313672
[TBL] [Abstract][Full Text] [Related]
50. Plasma reactive carbonyl species levels and risk of non-alcoholic fatty liver disease.
Liu S; Shi W; Li G; Jin B; Chen Y; Hu H; Liu L; Xie F; Chen K; Yin D
J Gastroenterol Hepatol; 2011 Jun; 26(6):1010-5. PubMed ID: 21265881
[TBL] [Abstract][Full Text] [Related]
51. Effect of dietary fat to produce non-alcoholic fatty liver in the rat.
Ahmed U; Redgrave TG; Oates PS
J Gastroenterol Hepatol; 2009 Aug; 24(8):1463-71. PubMed ID: 19702912
[TBL] [Abstract][Full Text] [Related]
52. Additional effect of low iron diet on iron reduction therapy by phlebotomy for chronic hepatitis C.
Kimura F; Hayashi H; Yano M; Yoshioka K; Matsumura T; Fukuda T; Shigeto N; Yamahara S; Koushi F; Mishima Y; Yoshino T; Tanimoto M; Kimura I
Hepatogastroenterology; 2005; 52(62):563-6. PubMed ID: 15816478
[TBL] [Abstract][Full Text] [Related]
53. Open-label pilot study of folic acid in patients with nonalcoholic steatohepatitis.
Charatcharoenwitthaya P; Levy C; Angulo P; Keach J; Jorgensen R; Lindor KD
Liver Int; 2007 Mar; 27(2):220-6. PubMed ID: 17311617
[TBL] [Abstract][Full Text] [Related]
54. [Rabbit model for the study of human NASH].
Otogawa K; Kawada N
Nihon Rinsho; 2006 Jun; 64(6):1043-7. PubMed ID: 16768107
[TBL] [Abstract][Full Text] [Related]
55. Laparoscopic findings in patients with nonalcoholic steatohepatitis.
Tanaka N; Ichijo T; Okiyama W; Mutou H; Misawa N; Matsumoto A; Yoshizawa K; Tanaka E; Kiyosawa K
Liver Int; 2006 Feb; 26(1):32-8. PubMed ID: 16420508
[TBL] [Abstract][Full Text] [Related]
56. Mitochondrial abnormality and oxidative stress in nonalcoholic steatohepatitis.
Kojima H; Sakurai S; Uemura M; Fukui H; Morimoto H; Tamagawa Y
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S61-6. PubMed ID: 17331168
[TBL] [Abstract][Full Text] [Related]
57. Iron load and liver enzymes in 10- and 13-year-olds.
Okuda M; Sasaki S; Kunitsugu I; Sakurai R; Yoshitake N; Hobara T
J Pediatr Gastroenterol Nutr; 2011 Mar; 52(3):333-8. PubMed ID: 21336162
[TBL] [Abstract][Full Text] [Related]
58. Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study.
Daubioul CA; Horsmans Y; Lambert P; Danse E; Delzenne NM
Eur J Clin Nutr; 2005 May; 59(5):723-6. PubMed ID: 15770222
[TBL] [Abstract][Full Text] [Related]
59. Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study.
Capanni M; Calella F; Biagini MR; Genise S; Raimondi L; Bedogni G; Svegliati-Baroni G; Sofi F; Milani S; Abbate R; Surrenti C; Casini A
Aliment Pharmacol Ther; 2006 Apr; 23(8):1143-51. PubMed ID: 16611275
[TBL] [Abstract][Full Text] [Related]
60. Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on non-alcoholic fatty liver disease patients: a preliminary study.
Sofi F; Giangrandi I; Cesari F; Corsani I; Abbate R; Gensini GF; Casini A
Int J Food Sci Nutr; 2010 Dec; 61(8):792-802. PubMed ID: 20465434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
